C/C(=N/N(C=O)C[n+]1ccccc1)C(CN(CC(C)C)CC(C)C)C(=O)Nc1ccc(C)cc1C.[Cl-]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?